Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01870492 · ClinicalTrials.gov registry record
Improving Patient Access to Stroke Therapy Study
A clinical trial, sponsored by Medical College of Wisconsin.
- Terminated
- Registry status
- 500
- Enrollment target
NCT01870492: Clinical Trial study, sponsored by Medical College of Wisconsin.
NCT01870492 is a clinical trial that was terminated before completion, run by Medical College of Wisconsin. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01870492 was terminated before completion, sponsored by Medical College of Wisconsin.
- TERMINATED
- Registry status
- 500 participants
- Enrollment target
Study Summary
Limited access is a major hurdle in the treatment of AIS; many hospitals, especially rural hospitals, do not have the infrastructure or medical support to effectively treat AIS patients.5 Failure to recognize the signs and symptoms of stroke by the patient and/or emergency medical services (EMS) is another barrier to the timely treatment of AIS. Several studies, including the Paul Coverdell National Acute Stroke Registry (PCNASR), have reported low rates of adherence to stroke care guidelines, suggesting that many AIS patients do not receive proper treatment according to established guidelines. Thus, there remains an increasing need to assess and address the barriers that prevent patient access to proper AIS treatment. Annually, approximately 20,000 patients are discharged from Wisconsin hospitals with the diagnosis of stroke and an estimated 4,000 patients die from stroke each year in WI. To date, there have been no statewide studies initiated in Wisconsin to assess the regional barriers to the treatment of AIS patients with thrombolytic or endovascular therapy, and many hospitals do not routinely collect and analyze AIS patient data. The goal of the Improving Patient Access to Stroke Therapy (IMPACT) pilot study is to engage community hospitals statewide to identify the regional barriers to AIS therapy in WI.
Interventions
- DRUG Activase
- DEVICE Endovascular therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-09-29 |
Why NCT01870492 stopped before completion
NCT01870492 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Activase is the first listed.
NCT01870492 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01870492 about?
NCT01870492 is a clinical study titled "Improving Patient Access to Stroke Therapy Study". Limited access is a major hurdle in the treatment of AIS; many hospitals, especially rural hospitals, do not have the infrastructure or medical support to effectively treat AIS patients.5 Failure to recognize the signs and symptoms of stroke by the patient and/or emergency medical services (EMS) is ...
What is the current status of trial NCT01870492?
This trial is currently terminated. The enrollment target is 500 participants. The study started on 2014-01. Estimated completion is 2015-09-29.
What interventions are being tested in trial NCT01870492?
The interventions under investigation include: Activase (DRUG), Endovascular therapy (DEVICE).
Who is sponsoring clinical trial NCT01870492?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia